12.1 C
Friday, March 1, 2024

Alfaisal University Signs an MOU with Hikma

Alfaisal University signed an agreement with Hikma Pharmaceutical, a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. Hikma creates high-quality medicines and makes them accessible to the people in need, it also helps to shape a healthier world that enriches all our communities. Hikma is a dependable source of over 760 high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians, and pharmacists need to treat patients across North America, MENA, and Europe. It has 32 manufacturing facilities, 8 R&D centers, and c8,80 employees worldwide.

This agreement was signed by Dr. Yousef Alyousef, Vice President for Graduate Studies, Research & Innovation, and Mr. Eyad Abuawad, VP, General Manager at Hikma-KSA.

Latest news


Related news



News Release

Breast cancer workshop (AlEqtesdaya, Al Jazirah, Al Riyadh :12 April 2010) COM International Achievement (AlHayat, Al Riyadh, Al Watan, Al Nadwah: 11 April 2011) Dallah...

The announcement of the academic program

RIYADH, May 16, 2007 — His Royal Highness Prince Khalid Al Faisal Ibn Abdul Aziz Al Saud, Chairman of the Board of Trustees of...

Memorandum of Understanding between Alfaisal University and the Security Forces Hospital

H.H. Prince Bandar Bin Saud Bin Khalid Al Saud, Chairman of the Executive Committee of the Board of Trustees of Alfaisal University, has signed...

Alfaisal University participates as an official sponsor in the Exhibition of Education and Training

Alfaisal University participated as an official sponsor in the Exhibition of Education and Training, organized by Madarat Alaridh Company from 20 to 23 May...

Swedish Scholarship Program for Saudi Graduates

Sweden is to establish a scholarship program for Saudi graduates and cooperate with the Kingdom in building a new engineering department in Riyadh as...